HIV is associated with an excess cancer risk, particularly of lymphoid malignancies. Modern
therapeutics has changed the landscape of HIV disease and typical opportunistic …

Cancer is the leading cause of death for HIV-infected persons in economically developed
countries, even in the era of antiretroviral therapy (ART). Lymphomas remain a leading …

With the advent of potent combination antiretroviral therapy (cART), incidence and mortality
rates of HIV-associated non-Hodgkin lymphomas (HIV-NHL) have decreased. By contrast …

We set out to assess feasibility and safety of allogeneic hematopoietic cell transplant in 17
persons with HIV in a phase II prospective multicenter trial. The primary endpoint was 100 …

ABSTRACT HIV is associated with an excess risk for lymphoid malignancies. Although the
risk of lymphoma has decreased in HIV-infected individuals in the era of effective …

The incidence of aggressive lymphoma in the setting of HIV infection is significantly
increased relative to the general population. Combination antiretroviral therapy (cART) for …

The Oncology Grand Rounds series is designed to place original reports published in the
Journal into clinical context. A case presentation is followed by a description of diagnostic …

Because of tremendous advances in HIV care, the survival of many people living with HIV
(PLWH) now approaches that of the general population. This has led to a shift in the types of …

Abstract HIV (Human Immunodeficiency Virus) and its consequence, AIDS (acquired
immunodeficiency syndrome) are responsible for a human tragedy of incalculable …

Blood and marrow transplant for lymphoma patients with HIV/A... : Current Opinion in
Oncology Blood and marrow transplant for lymphoma patients with HIV/AIDS : Current Opinion …